Similar articles for PMID: 16273722

Year	Number of Results
1991	1
1992	1
1998	1
1999	1
2000	3
2001	9
2002	10
2003	10
2004	6
2005	11
2006	7
2007	11
2008	11
2009	14
2010	14
2011	16
2012	24
2013	14
2014	17
2015	12
2016	17
2017	9
2018	16
2019	16
2020	22
2021	27
2022	14
2023	7
2024	0

1

Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.

Zhu K, Chen J, Chen S. Zhu K, et al. Hematology. 2005 Oct;10(5):365-70. doi: 10.1080/10245330410001714202. Hematology. 2005. PMID: 16273722

2

Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.

Zhu KE, Li JP, Zhang T, Zhong J, Chen J. Zhu KE, et al. Hematology. 2007 Apr;12(2):117-21. doi: 10.1080/10245330601111540. Hematology. 2007. PMID: 17454192

3

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Styczynski J, et al. Clin Infect Dis. 2013 Sep;57(6):794-802. doi: 10.1093/cid/cit391. Epub 2013 Jun 13. Clin Infect Dis. 2013. PMID: 23771985

4

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.

Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P. Omar H, et al. Transpl Infect Dis. 2009 Oct;11(5):393-9. doi: 10.1111/j.1399-3062.2009.00410.x. Epub 2009 May 26. Transpl Infect Dis. 2009. PMID: 19497070

5

Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M, Kopera M, Kruzel T, Najda J, Nowak K, Holowiecki J. Helbig G, et al. Haematologica. 2005 Nov;90 Suppl:ECR33. Haematologica. 2005. PMID: 16266924

6

[Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].

Chen DB, Wang Y, Song QJ, Shen DH. Chen DB, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):607-12. doi: 10.3760/cma.j.issn.0529-5807.2012.09.008. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23157829 Chinese.

7

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation.

Worth A, Conyers R, Cohen J, Jagani M, Chiesa R, Rao K, Goulden N, Veys P, Amrolia PJ. Worth A, et al. Br J Haematol. 2011 Nov;155(3):377-85. doi: 10.1111/j.1365-2141.2011.08855.x. Epub 2011 Sep 13. Br J Haematol. 2011. PMID: 21910716 Free article.

8

Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.

Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S. Ganne V, et al. Clin Transplant. 2003 Oct;17(5):417-22. doi: 10.1034/j.1399-0012.2003.00054.x. Clin Transplant. 2003. PMID: 14703923

9

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.

Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K. Kinch A, et al. Scand J Infect Dis. 2007;39(3):235-44. doi: 10.1080/00365540600978906. Scand J Infect Dis. 2007. PMID: 17366054

10

Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.

Zallio F, Primon V, Tamiazzo S, Pini M, Baraldi A, Corsetti MT, Gotta F, Bertassello C, Salvi F, Rocchetti A, Levis A. Zallio F, et al. Clin Transplant. 2013 Jul-Aug;27(4):E491-7. doi: 10.1111/ctr.12172. Epub 2013 Jun 19. Clin Transplant. 2013. PMID: 23781897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

287 results

Results by year